Basics Eton Pharmaceuticals, Inc. Common Stock IPO Date: November 13, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Market Cap: $421.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 2.78% Avg Daily Range (30 D): $0.58 | 3.20% Avg Daily Range (90 D): $0.50 | 3.17% Institutional Daily Volume Avg Daily Volume: .19M Avg Daily Volume (30 D): .39M Avg Daily Volume (90 D): .28M Trade Size Avg Trade Size (Sh.): 132 Avg Trade Size (Sh.) (30 D): 70 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 18 Avg Inst. Trade: $1.33M Avg Inst. Trade (30 D): $.7M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $.64M Avg Closing Trade (90 D): $.73M Avg Closing Volume: 386.57K     News May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals Apr 29, 2024 @ 8:30 PM Eton Pharmaceuticals to Report First Quarter 2024 ... Source: Eton Pharmaceuticals Mar 22, 2024 @ 6:00 AM Eton Pharmaceuticals Announces Acquisition of PKU... Source: Eton Pharmaceuticals Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.19 $-.06 $-.03 Diluted EPS Revenue $ 48.33M $ 17.28M $ 11.65M Gross Profit $ 28.27M $ 9.86M $ 6.48M Net Income / Loss $ -4.58M $ -1.57M $ -.6M Operating Income / Loss $ -2.27M $ -.47M $ .63M Cost of Revenue $ 20.06M $ 7.42M $ 5.17M Net Cash Flow $ -1.72M $ M $ -5.33M PE Ratio